LIVINGSTON, N.J.--(BUSINESS WIRE)-- Columbia Laboratories, Inc. (Nasdaq: CBRX) has renewed its license and supply agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for CRINONE ...
Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), a women's health specialty pharmaceutical company, today announced that the regulatory bodies of nine new European Union (EU) countries, including Poland ...
- Established, patient-preferred infertility treatment - - Expands Watson's Women's Health brand product portfolio - - Preterm birth clinical trials currently underway - - Company acquires 11.2 ...
Generics and specialty pharma Watson acquired a progesterone gel, marketed as Crinone and Prochieve, and added roughly 19 reps to its women’s health sales force. Watson now employs close to 400 reps, ...
BOSTON, Sept. 8, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and ...
* JUNIPER PHARMACEUTICALS INC - AMENDED AGREEMENT EXTENDS SUPPLY TERM AN ADDITIONAL 4.5 YEARS AND AT LEAST THROUGH TO DECEMBER 31, 2024 Source text for Eikon: Further company coverage: ...
LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) has amended its license and supply agreement with Merck Serono, a division of Merck KGaA (XETRA: MRK.DE), Darmstadt, ...
A simple, safe, relatively inexpensive hormone treatment might help some high-risk pregnant women carry their babies longer, a new study suggests, while improving the outlook for their infants. Such a ...
Co announces that an interim analysis of a pregnancy study comparing the efficacy of Crinone 8% to compounded intramuscular progesterone injections is now available online and will be published in ...
Generics and specialty pharma Watson Pharmaceuticals acquired a progesterone gel, marketed as Crinone and Prochieve, and added roughly 19 reps to its women’s health sales force. Watson now employs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results